South Dakota Medicaid and semaglutide
Wegovy for weight loss: no. Prior authorization form lists heart risk in members without diabetes and MASH in members without diabetes. Ozempic for weight loss: no; for type 2 diabetes South Dakota Medicaid must cover it. Read from South Dakota Department of Social Services, Division of Medicaid documents Nov 6, 2026.
In 2025 South Dakota Medicaid paid for 7,210 semaglutide prescriptions (Ozempic, Rybelsus, Wegovy), 46% of its GLP-1 prescriptions and 48th of the 50 states and DC. It reimbursed $6.9 million before rebates, $963 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 6,787 | $6.5 million | $964 |
| Rybelsus | 423 | $398,136 | $941 |
| Wegovy | 0 | $0 | $NaN |
Semaglutide in the states around South Dakota
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| South Dakota | 19 | $39/moWellmedr | 7,210 | Medicaid Wegovy: No |
| Iowa | 19 | $39/moWellmedr | 53,645 | Medicaid Wegovy: No |
| Minnesota | 19 | $39/moWellmedr | 165,896 | Medicaid Wegovy: Yes |
| Montana | 19 | $39/moWellmedr | 15,577 | Medicaid Wegovy: No |
| Nebraska | 19 | $39/moWellmedr | 24,156 | Medicaid Wegovy: No |
| North Dakota | 17 | $39/moWellmedr | 1,627 | Medicaid Wegovy: No |
| Wyoming | 19 | $39/moWellmedr | 593 | Medicaid Wegovy: No |



